Hematopoietic stem cell genetherapy with CRISPR/Cas9 inmetachromatic leukodystrophy(MLD)
Başlık çevirisi mevcut değil.
- Tez No: 723868
- Danışmanlar: Belirtilmemiş.
- Tez Türü: Yüksek Lisans
- Konular: Tıbbi Biyoloji, Medical Biology
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2018
- Dil: İngilizce
- Üniversite: Unıversıtı Malaya Um
- Enstitü: Yurtdışı Enstitü
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
Özet yok.
Özet (Çeviri)
Background: Metachromatic leukodystrophy (MLD) is a familial progressive neurologic dysfunction due to Arylsulfatase A (ASA) enzyme deficiency. The unfunctional enzyme cannot carry out its normal lysosomal process for sulfatides, therefore it leads neurodegeneration with a temporal decline. The one of the propitious therapy option is through lentiviral-mediated autologous transplantation of Hematopoietic Stem Cells (HSC) that targets the primary nervous system manifestations; however insertional mutagenesis due to random is a risk that cannot be disregarded. Thus, we have chosen to study an approach that combines autologous HSC Transplantation (HSCT) with CRISPR/Cas9 system and non-integrating repair templates to ensure target integration and thereby create a safe gene therapy. Methods: We assessed the ASA expression and enzyme activity in CD34+ HSCs. We utilized plasmid-encoded CRISPR/Cas9 system to target three specific mutations in ARSA gene locus in K562 cells. In addition, we used CRISPR/Cas9 system (encoded as mRNA/protein) and single-stranded DNA (ssDNA) repair template to integrate reporter protein/ARSA cDNA into the endogenous locus in CD34+ HSCs. The efficiency of integration was measured by reporter protein expression. Results: Our results demonstrated that CD34+ HSCs expresses enzymatically active Arylsulfatase A. Our designed sgRNAs targeting the three mutation sites of ARSA revealed that targeted indels induction in K562 is lower (up to 30%) due to plasmid encoded CRISPR/Cas9 system. The mRNA/protein encoded CRISPR/Cas9 system exhibited the improved efficacy in both K562 (up to 86%) and CD34+ HSCs (up to 56%). We found that out of the five tested sgRNAs, three of them resulted in moderate knockout efficacy (> 40%). The gene-repair quantification by flow cytometry showed that up to 3% site-specific integration of iv reporter gene was achieved at ARSA locus using Cas9 protein and single stranded DNA (ssDNA) in CD34+ HSCs. Conclusion: Our approach provides guidance on non-viral gene-correction in CD34+ HSCs using Cas9 protein and ssDNA. However, further optimization is indispensable to increase the homology directed repair (HDR) to attain a clinical benefit for MLD.
Benzer Tezler
- Kronik miyeloid lösemide CRISPR/CAS9 aracılı yeni nesil gen tedavisi
A new generation gene treatment of chronic myeloid leukemia through the mediation of CRISPR/cas9
MAKBULE NİHAN SOMUNCU
Doktora
Türkçe
2020
HematolojiNecmettin Erbakan ÜniversitesiTıbbi Genetik Ana Bilim Dalı
PROF. DR. MAHMUT SELMAN YILDIRIM
- Mezenşimal kök hücrelerin immün modülatör etkisinin hemofagositik sendrom klinik uygulamalarına temel oluşturmak üzere in vitro modelde incelenmesi
Investigation of the immune modulator effect of mesenchymal stem cells in in vitro model as the basis for hemophagocytic syndrome clinical applications
HANDAN SEVİM
- Hematopoetik kök hücre gen tedavi kültür koşulları ve engrafman optimizasyonu
Optimization of hematopoietic stem cell gene therapy culture conditions and engraftment
MEHMET EMİN ŞEKER
Yüksek Lisans
Türkçe
2021
Allerji ve İmmünolojiHacettepe ÜniversitesiKök Hücre Ana Bilim Dalı
DOÇ. DR. FATİMA SUSANNA FAUSTİNA AERTS KAYA
- AML kasumi-3 ve KG-1 hücre hatlarında hücre polaritesindeki değişiklikler ve in vitro hedef tedavisinin etkileri
Changes in cell polarity in aml kasumi-3 and KG-1 cell lines and the effects of in vitro target treatment
RASHAD RASULOV
- Assessment of the antioxidative and antiapoptotic effects of delta-opioid peptide D-ALA2-leu5-enkephalin on survival on hematopoietic stem cells
Delta-opioid peptide D-ALA-LEU5-enkephalin'in hematopoetik kök hücrelerin sağ kalımındaki rolü ve antioksidatif ve antiapoptotik etkilerinin araştırılması
AYNURA MAMMADOVA
Yüksek Lisans
İngilizce
2019
HematolojiHacettepe ÜniversitesiKök Hücre Ana Bilim Dalı
DR. ÖĞR. ÜYESİ FATİMA SUSANNA FAUSTİNA AERTS KAYA